Nuvation Bio Inc. logo NUVB - Nuvation Bio Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $20.50 DETAILS
HIGH: $21.00
LOW: $20.00
MEDIAN: $20.50
CONSENSUS: $20.50
UPSIDE: 195.82%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 31.7 83.2 41.9 13.1 4.8 3.1 5.7 0.7 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.9 5.6 0.4 3.3 2.6 2.1 4.2 1.5 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 30.8 77.6 41.4 9.8 2.3 1.0 1.5 (0.8) 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 30.7 35.0 34.3 28.8 27.4 24.6 29.3 27.7 454.3 12.8 15.4 18.6 18.6 18.8 16.9 21.3 28.9 20.7 22.0 17.1 14.0 15.9 9.3 8.6 7.3 7.3 8.8 4.0 6.1 6.1
SG&A Expenses 42.6 38.3 40.3 37.4 38.5 35.4 26.1 19.6 16.2 7.4 5.5 7.8 7.5 7.7 7.5 8.0 8.9 7.5 7.6 5.7 6.4 4.6 4.4 2.9 1.7 1.9 1.8 1.4 1.9 1.9
Other Expenses 8.6 0.4 0.9 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 81.8 73.7 75.5 66.2 65.8 60.0 55.4 47.3 470.5 20.2 20.8 26.3 26.1 26.5 24.3 29.3 37.9 28.2 29.6 22.8 20.4 20.5 13.8 11.5 9.0 9.2 10.6 5.5 8.0 8.0
Operating Income
Operating Income (51.0) 3.9 (34.0) (56.4) (63.6) (59.0) (53.9) (48.1) (470.4) (20.2) (20.8) (26.3) (26.1) (26.5) (24.3) (29.3) (37.9) (28.2) (29.6) (22.8) (20.4) (20.5) (13.8) (11.5) (9.0) (9.2) (10.6) (5.5) (8.0) (8.0)
Interest Expense 6.8 6.7 6.7 6.5 0.4 0.1 0.1 0.1 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 4.6 5.1 5.3 6.0 4.8 5.3 6.1 6.7 7.1 7.1 7.0 6.5 6.1 5.0 3.5 2.1 0.8 1.0 0.9 0.8 0.8 0.4 0.5 0.4 0.5 0.5 0.6 0.6 1.3 1.3
Profitability
EBITDA (55.5) 12.6 (29.4) (54.8) (58.2) (52.9) (49.1) (40.9) (462.1) (14.7) (13.7) (19.6) (20.6) (21.7) (20.8) (27.1) (34.8) (21.2) (25.1) (21.9) (19.3) (20.5) (13.7) (11.5) (9.0) (9.2) (10.6) (5.5) 0 0
EBIT (56.1) 12.1 (29.9) (55.3) (58.6) (53.2) (49.4) (41.1) (462.4) (14.8) (13.8) (19.6) (20.6) (21.7) (20.8) (27.2) (34.9) (21.3) (25.1) (22.0) (19.3) (20.5) (13.8) (11.5) (9.0) (9.2) (10.6) (5.5) (8.0) (8.0)
Income Before Tax (62.8) 5.4 (36.6) (55.8) (59.0) (53.2) (49.4) (41.2) (462.5) (14.8) (13.8) (19.6) (20.6) (21.7) (20.8) (27.2) (34.9) (21.3) (25.1) (22.0) (19.3) (20.4) (13.3) (11.0) (8.6) (8.7) (10.0) (4.9) (9.3) (9.3)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (62.8) 5.4 (36.6) (55.8) (59.0) (53.2) (49.4) (41.2) (462.5) (14.8) (13.8) (19.6) (20.6) (21.7) (20.8) (27.2) (34.9) (21.3) (25.1) (22.0) (19.3) (20.4) (13.3) (11.0) (8.6) (8.7) (10.0) (4.9) (9.3) (9.3)
Per Share Data
EPS (Basic) -0.18 0.02 -0.11 -0.16 -0.17 -0.16 -0.15 -0.15 -1.89 -0.07 -0.06 -0.09 -0.09 -0.10 -0.10 -0.12 -0.16 -0.10 -0.12 -0.11 -0.09 -0.12 -0.10 -0.05 -0.04 -0.04 -0.04 -0.02 -0.05 -0.05
EPS (Diluted) -0.18 0.01 -0.11 -0.16 -0.17 -0.16 -0.15 -0.15 -1.89 -0.07 -0.06 -0.09 -0.09 -0.10 -0.10 -0.12 -0.16 -0.10 -0.12 -0.11 -0.09 -0.12 -0.10 -0.05 -0.04 -0.04 -0.04 -0.02 -0.05 -0.05
Shares Outstanding 348.8 347.3 344.3 342.4 340.7 338.6 336.9 273.6 244.7 219.0 218.9 218.9 218.8 218.7 218.5 218.3 216.6 213.4 202.5 207.1 204.0 169.7 133.6 217.7 217.7 217.7 237.4 221.8 183.7 183.7
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 258.6 125.4 164.1 98.9 248.0 48.0 35.7 30.0 34.3 34.5 42.6 24.4 50.1 30.1 101.1 138.7 102.3 106.2 132.4 344.6 449.5 638.9 29.8 8.3 9.3 0 3.5 (0.1)
Short-Term Investments 402.4 408.3 365.1 450.1 359.8 413.7 467.0 519.1 542.9 562.5 568.6 594.9 580.8 616.5 559.9 535.3 601.5 631.5 633.0 447.2 357.1 185.8 186.0 88.4 95.3 0 115.4 0.3
Net Receivables 31.7 26.0 19.4 13.8 6.7 5.5 16.3 4.3 4.0 4.3 3.7 3.0 2.8 2.3 2.5 2.4 2.7 2.5 3.0 1.8 2.0 1.0 1.1 0 0 0 0 0
Inventory 19.9 15.8 11.4 5.7 0.6 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 13.9 16.0 11.5 8.9 8.3 8.4 7.3 11.6 6.0 6.8 1.5 3.0 3.5 3.7 3.8 0 0 0 0 0 0 0 2.9 1.1 0.7 0 0.8 0
Total Current Assets 726.4 591.5 571.5 577.5 623.2 475.6 526.3 565.0 587.2 608.1 616.4 625.3 637.2 652.6 667.3 681.4 714.3 748.0 772.1 796.6 813.1 830.9 220.7 98.3 105.8 0 119.9 0.1
Non-Current Assets
Property, Plant & Equipment 4.0 4.1 4.5 4.9 5.3 5.9 3.0 3.2 3.5 3.9 4.3 4.8 4.0 4.4 4.7 5.0 5.3 3.3 3.7 0.8 0.8 0.8 0.7 0.7 0.7 0 0.6 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 10.3 10.8 11.2 11.7 12.1 4.4 4.6 2.8 2.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 3.8 3.8 7.6 7.5 6.6 6.6 6.8 0.6 1.2 1.2 0.7 0.7 0.1 0.1 0.1 0.1 0.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0 0.4 (0.1)
Total Non-Current Assets 18.1 18.7 23.3 24.0 24.0 16.9 14.4 6.6 7.6 5.1 5.0 5.5 4.2 4.5 4.8 5.1 5.5 3.8 4.1 1.2 1.2 1.2 1.1 1.1 1.1 0 1.1 (0.1)
Total Assets 744.5 610.2 594.8 601.6 647.2 492.5 540.6 571.6 594.8 613.1 621.5 630.9 641.4 657.1 672.1 686.5 719.7 751.8 776.2 797.8 814.3 832.1 221.8 99.4 106.9 0 121.0 0
Current Liabilities
Account Payables 12.1 22.4 9.5 15.4 22.4 10.5 6.3 12.4 5.2 2.4 2.2 2.4 2.6 2.9 2.1 3.0 12.7 9.7 3.9 5.2 4.5 6.0 2.2 4.3 1.5 0 2.0 0
Short-Term Debt 5.9 7.6 7.6 5.6 5.6 5.7 6.3 8.4 11.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 8.9 0 0 6.7 9.7 10.8 11.1 12.9 12.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 13.0 49.5 65.1 6.0 2.8 0 14.8 0 0 0 4.3 0 0 0 4.0 0 0 0 6.2 0 5.6 4.0 3.2 0.5 0 0 0.0 0
Total Current Liabilities 86.8 79.5 82.2 68.1 66.4 52.8 58.2 59.0 51.1 15.8 14.0 16.1 13.4 12.6 13.2 14.0 21.3 21.4 16.9 13.3 10.1 10.0 6.6 7.4 3.9 0 3.2 0
Non-Current Liabilities
Long-Term Debt 244.5 2.2 2.5 47.1 47.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 8.2 57.1 58.5 146.4 145.1 2.8 2.1 0.9 276.4 1.8 0.4 0.6 1.0 0.7 0.8 1.2 1.6 4.7 11.0 15.1 15.1 15.6 0.2 0.1 0.1 0 0 0
Total Non-Current Liabilities 403.9 211.2 206.9 207.5 208.0 20.3 18.6 9.8 286.5 3.3 2.4 3.1 3.4 3.4 3.9 4.5 5.4 6.8 13.2 15.1 15.2 15.7 0.2 0.1 0.1 0 0 0
Total Liabilities 490.6 290.7 289.1 275.7 274.3 73.0 76.8 68.9 337.6 19.1 16.4 19.3 16.8 16.0 17.1 18.6 26.7 28.2 30.2 28.4 25.3 25.7 6.7 7.6 4.1 0 3.2 0.7
Stockholders' Equity
Common Stock 1,429.3 1,431.2 1,421.3 1,404.8 1,396.2 1,382.9 1,374.0 1,362.6 1,078.5 952.8 947.7 943.9 938.4 932.7 927.6 922.2 919.0 913.9 910.0 906.6 903.9 901.7 289.5 10.8 10.5 0 9.8 0
Retained Earnings (1,172.8) (1,110.0) (1,115.4) (1,078.8) (1,023.0) (964.0) (910.7) (861.3) (820.1) (357.6) (342.8) (329.0) (309.4) (288.7) (267.0) (246.2) (219.0) (184.1) (162.8) (137.7) (115.7) (96.4) (76.0) (62.7) (51.6) 0 (34.3) 0
Accumulated Other Comprehensive Income (2.6) (1.7) (0.2) (0.1) (0.3) 0.5 0.6 1.4 (1.3) (1.2) 0.2 (3.3) (4.4) (2.9) (5.5) (8.1) (7.0) (6.2) (1.2) 0.4 0.8 1.0 1.6 1.8 2.2 0 0.4 (0.7)
Total Stockholders' Equity 253.9 319.6 305.7 325.9 372.9 419.5 463.8 502.7 257.2 594.0 605.1 611.6 624.6 641.1 655.1 667.9 693.1 723.6 746.0 769.4 788.9 806.3 215.1 91.8 102.9 0 117.7 (0.7)
Total Liabilities & Equity 744.5 610.2 594.8 601.6 647.2 492.5 540.6 571.6 594.8 613.1 621.5 630.9 641.4 657.1 672.1 686.5 719.7 751.8 776.2 797.8 814.3 832.1 221.8 99.4 106.9 0 121.0 (0.7)
Debt Metrics
Total Debt 252.1 9.8 10.1 57.5 57.8 11.4 8.9 11.2 14.7 3.5 4.0 4.5 3.7 4.0 4.3 4.5 4.7 2.8 3.1 0 0 0 0 0 0 0 0 0
Net Debt (6.5) (115.6) (153.9) (41.3) (190.2) (36.6) (26.8) (18.8) (19.6) (31.0) (38.6) (19.9) (46.4) (26.1) (96.8) (134.2) (97.6) (103.4) (129.4) (344.6) (449.5) (638.9) (29.8) (8.3) (9.3) 0 (3.5) 0.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (5.4) 5.4 168.0 (55.8) (59.0) (53.2) (49.4) (41.2) (462.5) (14.8) (13.8) (19.6) (20.6) (21.7) (20.8) (27.2) (34.9) (21.3) (25.1) (22.0) (19.3) (20.4) (13.3) (11.0) (8.6) (8.7) (10.0) (4.9) (9.3) (9.3)
Depreciation & Amortization (0.5) 0.5 (1.2) 0.5 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0
Stock-Based Compensation (9.0) 9.0 (27.9) 8.0 12.0 7.9 10.2 7.5 9.6 5.0 3.7 5.4 5.5 4.8 5.0 2.9 4.8 3.6 2.8 2.7 2.2 1.6 1.1 0.3 0.4 0.3 0 0 0 0
Change in Working Capital 11.5 (11.5) 5.7 (8.7) 0.2 2.8 (6.7) 5.0 (6.1) (4.6) (1.4) 1.8 0.5 (0.3) 0.2 (4.4) 3.7 (2.9) 0.8 4.9 (0.3) (0.6) (1.2) 2.6 1.2 (0.5) (0.5) (0.0) 0.0 0.0
Other Non-Cash Items (1.6) 1.6 (174.4) 3.0 (1.8) (0.3) (0.5) (2.5) 421.5 (1.4) (3.6) (3.8) (2.9) (2.2) (0.5) 0.5 (0.6) (4.3) (2.0) 1.1 0.6 4.7 0.4 0.0 0.2 0.2 1.1 (2.3) 5.4 5.4
Operating Cash Flow (5.1) 5.1 (29.7) (52.9) (48.2) (42.6) (46.3) (31.1) (37.3) (15.7) (15.0) (16.2) (17.5) (19.3) (16.2) (28.1) (26.9) (24.9) (23.5) (13.1) (16.8) (14.7) (12.9) (8.0) (6.8) (8.7) (9.4) (7.2) (3.9) (3.9)
Investing Activities
Capital Expenditure 0.0 (0.0) (0.1) (0.0) (0.2) (0.1) 0.0 (0.1) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.0) (0.1) (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.1) (0.3) (0.3) 0 0
Acquisitions 0 0 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (67.7) (82.1) 309.5 (167.1) (81.7) (60.7) (32.0) (85.7) (93.5) (128.4) (148.7) (110.8) (206.8) (237.0) (137.7) (119.9) (131.0) (131.7) (254.5) (123.2) (207.2) (24.5) (136.1) (1.1) (4.6) (1.6) 0 0 0 0
Sales/Maturities of Investments 73.9 38.6 (330.2) 78.5 136.7 115.0 83.9 114.9 115.3 136.0 181.9 101.3 244.2 185.0 115.9 184.2 157.8 126.1 65.3 31.5 34.6 23.5 37.8 7.6 15.4 12.3 0 0 0 0
Other Investing Activities 0 0 99.5 0 0 0 0 0 12.5 0 0.0 0 0 0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 7.6 (122.8) 0 0
Investing Cash Flow 6.0 (43.6) 87.1 (96.6) 54.9 54.2 51.8 29.1 34.3 7.5 33.2 (9.6) 37.3 (52.0) (21.8) 64.2 26.6 (5.6) (189.3) (91.7) (172.6) (1.1) (98.3) 6.5 10.8 10.6 7.2 (123.1) 0 0
Financing Activities
Net Debt Issuance 182.9 0 (191.5) (6.7) 198.7 (0.5) (2.1) (3.2) 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Stock Repurchased (17.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (0.9) 201.5 6.6 (6.6) 1.1 1.2 1.7 2.0 0.0 0.1 0.1 0.1 0.3 0.4 0.3 (3.6) 4.3 0.5 (0.0) 0.1 625.0 132.6 0.5 0 0 (1.2) (1.8) 72.8 72.8
Financing Cash Flow 170.5 0.0 8.1 0.5 193.4 0.5 (0.9) (1.5) 2.7 0.0 0.1 0.1 0.1 0.3 0.4 0.3 (3.6) 4.3 0.5 (0.0) 0.1 625.0 132.6 0.5 0 0 (0.2) (1.8) 72.8 72.8
Cash Position
Net Change in Cash 171.1 (38.7) 65.2 (149.1) 200.0 12.3 5.7 (4.2) (0.2) (8.1) 18.3 (25.7) 20.0 (71.0) (37.6) 36.4 (3.9) (26.2) (212.2) (104.9) (189.4) 609.1 21.4 (1.0) 4.0 1.9 (2.4) (132.0) 68.9 68.9
Cash at Beginning 125.4 164.1 98.9 248.0 48.0 35.7 30.0 34.3 34.5 42.6 24.4 50.1 30.1 101.1 138.7 102.3 106.2 132.4 344.6 449.5 638.9 29.8 8.3 9.3 5.4 3.5 5.9 137.9 69.0 0
Cash at End 296.5 125.4 164.1 98.9 248.0 48.0 35.7 30.0 34.3 34.5 42.6 24.4 50.1 30.1 101.1 138.7 102.3 106.2 132.4 344.6 449.5 638.9 29.8 8.3 9.3 5.4 3.5 5.9 137.9 68.9
Free Cash Flow (5.0) 5.0 (29.8) (52.9) (48.4) (42.7) (46.3) (31.2) (37.3) (15.7) (15.0) (16.2) (17.5) (19.3) (16.2) (28.2) (27.1) (24.9) (23.6) (13.2) (16.8) (14.8) (13.0) (8.1) (6.8) (8.8) (9.7) (7.5) (3.9) (3.9)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 31.7 83.2 41.9 13.1 4.8 3.1 5.7 0.7 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 30.8 77.6 41.4 9.8 2.3 1.0 1.5 (0.8) 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (51.0) 3.9 (34.0) (56.4) (63.6) (59.0) (53.9) (48.1) (470.4) (20.2) (20.8) (26.3) (26.1) (26.5) (24.3) (29.3) (37.9) (28.2) (29.6) (22.8) (20.4) (20.5) (13.8) (11.5) (9.0) (9.2) (10.6) (5.5) (8.0) (8.0)
Net Income (62.8) 5.4 (36.6) (55.8) (59.0) (53.2) (49.4) (41.2) (462.5) (14.8) (13.8) (19.6) (20.6) (21.7) (20.8) (27.2) (34.9) (21.3) (25.1) (22.0) (19.3) (20.4) (13.3) (11.0) (8.6) (8.7) (10.0) (4.9) (9.3) (9.3)
EPS (Diluted) -0.18 0.01 -0.11 -0.16 -0.17 -0.16 -0.15 -0.15 -1.89 -0.07 -0.06 -0.09 -0.09 -0.10 -0.10 -0.12 -0.16 -0.10 -0.12 -0.11 -0.09 -0.12 -0.10 -0.05 -0.04 -0.04 -0.04 -0.02 -0.05 -0.05
Balance Sheet
Cash & Equivalents 258.6 125.4 164.1 98.9 248.0 48.0 35.7 30.0 34.3 34.5 42.6 24.4 50.1 30.1 101.1 138.7 102.3 106.2 132.4 344.6 449.5 638.9 29.8 8.3 9.3 0 3.5 (0.1)
Total Assets 744.5 610.2 594.8 601.6 647.2 492.5 540.6 571.6 594.8 613.1 621.5 630.9 641.4 657.1 672.1 686.5 719.7 751.8 776.2 797.8 814.3 832.1 221.8 99.4 106.9 0 121.0 0
Total Debt 252.1 9.8 10.1 57.5 57.8 11.4 8.9 11.2 14.7 3.5 4.0 4.5 3.7 4.0 4.3 4.5 4.7 2.8 3.1 0 0 0 0 0 0 0 0 0
Stockholders' Equity 253.9 319.6 305.7 325.9 372.9 419.5 463.8 502.7 257.2 594.0 605.1 611.6 624.6 641.1 655.1 667.9 693.1 723.6 746.0 769.4 788.9 806.3 215.1 91.8 102.9 0 117.7 (0.7)
Cash Flow
Operating Cash Flow (5.1) 5.1 (29.7) (52.9) (48.2) (42.6) (46.3) (31.1) (37.3) (15.7) (15.0) (16.2) (17.5) (19.3) (16.2) (28.1) (26.9) (24.9) (23.5) (13.1) (16.8) (14.7) (12.9) (8.0) (6.8) (8.7) (9.4) (7.2) (3.9) (3.9)
Capital Expenditure 0.0 (0.0) (0.1) (0.0) (0.2) (0.1) 0.0 (0.1) 0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.1) (0.1) (0.2) (0.0) (0.1) (0.0) (0.0) (0.1) (0.0) (0.0) (0.0) (0.1) (0.3) (0.3) 0 0
Free Cash Flow (5.0) 5.0 (29.8) (52.9) (48.4) (42.7) (46.3) (31.2) (37.3) (15.7) (15.0) (16.2) (17.5) (19.3) (16.2) (28.2) (27.1) (24.9) (23.6) (13.2) (16.8) (14.8) (13.0) (8.1) (6.8) (8.8) (9.7) (7.5) (3.9) (3.9)